Editas Medicine (EDIT) Operating Income (QoQ) (2015 - 2025)
Editas Medicine (EDIT) Operating Income (QoQ) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Editas Medicine | 245.95 Mn | 99.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 52.37% |
| Jun 30, 2025 | 32.32% |
| Mar 31, 2025 | -63.46% |
| Dec 31, 2024 | 29.05% |
| Sep 30, 2024 | 8.67% |
| Jun 30, 2024 | -7.33% |
| Mar 31, 2024 | -179.57% |
| Dec 31, 2023 | 52.23% |
| Sep 30, 2023 | -13.76% |
| Jun 30, 2023 | 13.48% |
| Mar 31, 2023 | 19.68% |
| Dec 31, 2022 | -10.30% |
| Sep 30, 2022 | -6.06% |
| Jun 30, 2022 | -6.87% |
| Mar 31, 2022 | -21.97% |
| Dec 31, 2021 | -6.00% |
| Sep 30, 2021 | 29.15% |
| Jun 30, 2021 | 2.61% |
| Mar 31, 2021 | 13.65% |
| Dec 31, 2020 | -832.81% |